We assign a fundamental rating of 6 out of 10 to VCYT. VCYT was compared to 524 industry peers in the Biotechnology industry. While VCYT has a great health rating, its profitability is only average at the moment. VCYT is growing strongly while it is still valued neutral. This is a good combination! This makes VCYT very considerable for growth investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROIC | 2.93% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 15.39 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 95.24 | ||
| Fwd PE | 33.82 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.2 | ||
| EV/EBITDA | 33.34 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
36.19
+1.33 (+3.82%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 95.24 | ||
| Fwd PE | 33.82 | ||
| P/S | 5.78 | ||
| P/FCF | 29.2 | ||
| P/OCF | 26.56 | ||
| P/B | 2.27 | ||
| P/tB | 7.19 | ||
| EV/EBITDA | 33.34 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROCE | 3.71% | ||
| ROIC | 2.93% | ||
| ROICexc | 4.08% | ||
| ROICexgc | 54.52% | ||
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% | ||
| FCFM | 19.79% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.07% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.6% | ||
| Profit Quality | 323.21% | ||
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 | ||
| Altman-Z | 15.39 |
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 95.24 and the Price/Book (PB) ratio is 2.27.
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.